Literature DB >> 28776129

Comparative Effectiveness Research in Pediatric Respiratory Disease: Promise and Pitfalls.

Kathleen J Ramos1, Ranjani Somayaji2, David P Nichols3,4, Christopher H Goss5,6,7,8.   

Abstract

Comparative effectiveness research (CER) has become increasing central to clinical research in medicine. CER seeks to conduct clinical trials that compare different commonly used interventions in real-world settings (pragmatic clinical trials) and use a multitude of sources of evidence (including registries and cohort studies) to inform clinical decision making. CER also ensures that stakeholders (patients, families, care providers, insurers) have a voice in the research process by integrating formal stakeholder engagement as part of the research. This innovative approach to clinical research has distinct benefits and pitfalls. This review first defines what CER is and then describes some of its benefits and then pitfalls. The focus is on the role of CER in pediatrics.

Entities:  

Mesh:

Year:  2018        PMID: 28776129      PMCID: PMC5906049          DOI: 10.1007/s40272-017-0256-y

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  38 in total

1.  Patient-Centered Outcomes Research Institute: the intersection of science and health care.

Authors:  Carolyn Clancy; Francis S Collins
Journal:  Sci Transl Med       Date:  2010-06-23       Impact factor: 17.956

2.  Learning About Machine Learning: The Promise and Pitfalls of Big Data and the Electronic Health Record.

Authors:  Rahul C Deo; Brahmajee K Nallamothu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-11-08

3.  Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution.

Authors:  Gregory S Sawicki; James E Signorovitch; Jie Zhang; Dominick Latremouille-Viau; Markus von Wartburg; Eric Q Wu; Lizheng Shi
Journal:  Pediatr Pulmonol       Date:  2011-08-03

4.  Validation of a predictive survival model in Italian patients with cystic fibrosis.

Authors:  Roberto Buzzetti; Gianfranco Alicandro; Laura Minicucci; Sara Notarnicola; Maria Lucia Furnari; Gabriella Giordano; Vincenzina Lucidi; Enza Montemitro; Valeria Raia; Giuseppe Magazzù; Giuseppe Vieni; Serena Quattrucci; Alessandro Ferrazza; Rolando Gagliardini; Natalia Cirilli; Donatello Salvatore; Carla Colombo
Journal:  J Cyst Fibros       Date:  2011-09-23       Impact factor: 5.482

5.  Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia.

Authors:  K L Fraser; D E Tullis; Z Sasson; R H Hyland; K S Thornley; P J Hanly
Journal:  Chest       Date:  1999-05       Impact factor: 9.410

6.  Improving rate of decline of FEV1 in young adults with cystic fibrosis.

Authors:  C Que; P Cullinan; D Geddes
Journal:  Thorax       Date:  2005-12-29       Impact factor: 9.139

7.  Leukotriene antagonists as first-line or add-on asthma-controller therapy.

Authors:  David Price; Stanley D Musgrave; Lee Shepstone; Elizabeth V Hillyer; Erika J Sims; Richard F T Gilbert; Elizabeth F Juniper; Jon G Ayres; Linda Kemp; Annie Blyth; Edward C F Wilson; Stephanie Wolfe; Daryl Freeman; H Miranda Mugford; Jamie Murdoch; Ian Harvey
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

8.  Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.

Authors:  E Hentschel; G Brandstätter; B Dragosics; A M Hirschl; H Nemec; K Schütze; M Taufer; H Wurzer
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

9.  Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'.

Authors:  Miriam M Treggiari; Margaret Rosenfeld; Nicole Mayer-Hamblett; George Retsch-Bogart; Ronald L Gibson; Judy Williams; Julia Emerson; Richard A Kronmal; Bonnie W Ramsey
Journal:  Contemp Clin Trials       Date:  2009-01-15       Impact factor: 2.226

10.  Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study.

Authors:  Anne L Stephenson; Jenna Sykes; Sanja Stanojevic; Bradley S Quon; Bruce C Marshall; Kristofer Petren; Josh Ostrenga; Aliza K Fink; Alexander Elbert; Christopher H Goss
Journal:  Ann Intern Med       Date:  2017-03-14       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.